Skip to main content
Show — Main navigation Hide — Main navigation
  • Home
  • About
    • The Chair
    • Inquiry Team
    • Expert Groups
    • Inquiry Intermediaries
    • Core Participants
    • Legal Representatives
    • Financial Reports
  • Approach
    • Terms of reference
    • List of Issues
    • Statements of approach
    • Inquiry Principles
  • News
    • News
    • Newsletter Archive
  • Reports
    • Compensation Framework Study
    • First Interim Report
    • Second Interim Report
    • The Inquiry Report
  • Publication Day
  • Evidence
    • Evidence
    • Hearings Archive
  • Compensation
  • Support
    • Confidential Psychological Support
    • Interim Payments
    • Support Groups
    • Get in touch
    • Infected Blood Support Schemes
    • Treatment and aftercare
    • Medical Evidence
    • Expenses Guidance
Accessibility Tool
  • Zoom in
  • Zoom out
  • Reset
  • Contrast
  • Accessibility tool
Get in touch

Quick Exit

Dr Delamore preferred to administer cryoprecipitate but observed that if freeze-dried concentrate could be altered to be dissolved more easily and in smaller volume, "we would probably choose that preparation in preference to cryoprecipitate."

  • Read more about Dr Delamore preferred to administer cryoprecipitate but observed that if freeze-dried concentrate could be altered to be dissolved more easily and in smaller volume, "we would probably choose that preparation in preference to cryoprecipitate."

Manchester Royal Infirmary's role was described in an article: "today with modern methods of treatment and patient assessment.. haemophiliacs are able to lead a near-normal, albeit hazardous, life. Their great salvation comes in small plastic bags containing as the cryoprecipitate."

  • Read more about Manchester Royal Infirmary's role was described in an article: "today with modern methods of treatment and patient assessment.. haemophiliacs are able to lead a near-normal, albeit hazardous, life. Their great salvation comes in small plastic bags containing as the cryoprecipitate."

One of the aims of the appointment of Dr Wensley was to create a better understanding with the RTC and "a greater availability of cryoprecipitate and better treatment for all
haemophiliacs."

  • Read more about One of the aims of the appointment of Dr Wensley was to create a better understanding with the RTC and "a greater availability of cryoprecipitate and better treatment for all haemophiliacs."

Most patients being treated for haemophilia who were treated at the Manchester Royal Infirmary would have been informed that there was a high likelihood of them having AIDS. They were informed either by letter or through routine appointments.

  • Read more about Most patients being treated for haemophilia who were treated at the Manchester Royal Infirmary would have been informed that there was a high likelihood of them having AIDS. They were informed either by letter or through routine appointments.

The reference centre at the Manchester Royal Infirmary was part of a regional haemophilia service in North West England, which included Manchester Children's Hospital and the Lancaster Haemophilia Centre.

  • Read more about The reference centre at the Manchester Royal Infirmary was part of a regional haemophilia service in North West England, which included Manchester Children's Hospital and the Lancaster Haemophilia Centre.

Professor Bloom held that he existence of the viruses causing serum hepatitis was well known to doctors caring for haemophiliacs during the 1960's, 1970's and later.

  • Read more about Professor Bloom held that he existence of the viruses causing serum hepatitis was well known to doctors caring for haemophiliacs during the 1960's, 1970's and later.

Professor Bloom held, that around 1983-1984, that it was not necessary to inform patients or the parents of patients of the risks of AIDS.

  • Read more about Professor Bloom held, that around 1983-1984, that it was not necessary to inform patients or the parents of patients of the risks of AIDS.

Following the fifth meeting by the AIDS Group, on 17 June 1985, more centres had transitioned to using commercial heat-treated Factor 9.

  • Read more about Following the fifth meeting by the AIDS Group, on 17 June 1985, more centres had transitioned to using commercial heat-treated Factor 9.

The AIDS Advisory document recorded that heat-treated commercial factor products were available. On the subject, Professor Bloom stated that during the early 1980s, several observers noted that there appeared to be a reduced risk of HIV infection and/or immunological abnormalities in patients with haemophilia B compared to those with haemophilia A.

  • Read more about The AIDS Advisory document recorded that heat-treated commercial factor products were available. On the subject, Professor Bloom stated that during the early 1980s, several observers noted that there appeared to be a reduced risk of HIV infection and/or immunological abnormalities in patients with haemophilia B compared to those with haemophilia A.

Professor Bloom stated that by 1 January 1985, all Haemophilia Centres should have received the AIDS advisory document.

  • Read more about Professor Bloom stated that by 1 January 1985, all Haemophilia Centres should have received the AIDS advisory document.

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 76
  • Page 77
  • Page 78
  • Page 79
  • Current page 80
  • Page 81
  • Page 82
  • Page 83
  • Page 84
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Inquiry

  • Home
  • About
  • Approach
  • Participate
  • News
  • Evidence
  • Support
  • Get in touch

Legal

  • Terms & Conditions
  • Cookies notice
  • Privacy Notice
  • Accessibility tool

Address

Infected Blood Inquiry
5th Floor
Aldwych House
71-91 Aldwych
London
WC2B 4HN
 
Images of individuals on the website are used with the agreement of those featured or are stock images.

Follow us

© Crown copyright. Licensed under the Open Government Licence v3.0 except where otherwise stated.